Research programme: camptothecin pro-drugs - Dekk-TecAlternative Names: 7-butyl-10-amino-camptothecin pro-drug; BACPT; BACPTDP
Latest Information Update: 03 Dec 2010
At a glance
- Originator Dekk-Tec
- Class Camptothecins
- Mechanism of Action DNA topoisomerase I inhibitors; Hypoxia-inducible factor 1 inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Preclinical Cancer
Most Recent Events
- 19 Nov 2009 Preclinical trials in Cancer in USA (unspecified route)